Drug Companies Update January 2009
Mergers, acquisitions & Joint Ventures
- BioTie Therapies has acquired Elbion
- BTG has acquired Protherics
- Cytrx has acquired Innovive
- Invitrogen and Applied Biosystems have merged to form Life Technologies
- Lilly has acquired ImClone Systems
- Oxford Genome Sciences changed its name to Oxford Biotherapeutics
- Patrys acquired Acceptys' assets
New Companies
- Avineuro is a pharmaceutical company discovering and developing novel small molecules for unmet medical needs in neurology and psychiatry.
- BioCis is a drug development company focused on investigation of treatments for inflammation, allergy and cancer.
- Capricor is a biotechnology company focused on the development of stem cell therapies for the treatment of heart disease.
- Chaperone Technologies is a biotechnology company developing a new class of anti-microbials.
- ConjuGate is a biotechnology company developing anti-infective and anti-cancer drugs.
- Indus Biotech is a biotechnology company developing therapies derived from botanical sources for a variety of diseases including inflammatory, metabolic and degenerative diseases.
- InVasc is a pharmaceutical company focused on the development of small molecule pharmaceuticals for the treatment of heart and circulatory disorders.
- Memgen is a clinical stage biotechnology company focused on improving overall survival in cancer patients.
- Neorphys is a pharmaceutical company developing proprietary analgesic drugs with low side-effects, especially with regard to the gastrointestinal tract.
- PARI Pharma is a pharmaceutical company developing aerosol delivery technologies and therapeutics.
- Provecs Medical is a biotechnology company developing novel immunotherapeutics for the treatment of cancer.
- QR Pharma is a biotechnology company focused on developing treatments for Alzheimer's disease.
- Thrombotech is a biotechnology company focused on the development of thrombolytic drugs.
- TK signal is a biopharmaceutical company developing anti-cancer drugs and radiopharmaceuticals for cancer imaging.
- Treague is a pharmaceutical company developing anti-malarials on a not-for-profit basis, where there is an unmet medical need.
- ZaBeCor is a biotechnology company developing siRNA, antisense and other molecular therapies for the treatment of respiratory, inflammatory and infectious diseases.
